Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma

Cytokine

Volumn 64, Issue 2, 2013, Pages 497-502

  Kamatani, T ^a   Shiogama, S ^a   Yoshihama, Y ^a   Kondo, S ^a   Shirota, T ^a   Shintani, S ^a  

^a SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Cytokines; Interleukin 1 beta; Oral squamous cell carcinoma; Unstimulated whole saliva

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA; SALIVA LEVEL; UNSTIMULATED WHOLE SALIVA;

CYTOKINES; INTERLEUKIN-1 BETA; ORAL SQUAMOUS CELL CARCINOMA; UNSTIMULATED WHOLE SALIVA;

ANTIBODIES, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CELL EXTRACTS; CELL LINE, TUMOR; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; RNA, MESSENGER; SALIVA; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885176844     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.08.011     Document Type: Article

References (24)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009, 45:309-316.
2. Streckfus C., Bigler L., Tucci M., Thigpen J.T. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest 2000, 18:101-109.
3. Gorelik E., Landsittel D.P., Marrangoni A.M., Modugno F., Velikokhatnaya L., Winans M.T., et al. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:981-987.
4. Yio X.Y., Jiang J., Yin F.Z., Ruan K.H. Highly sensitive sandwich enzyme immunoassay for alpha-fetoprotein in human saliva. Ann Clin Biochem 1992, 29:519-522.
5. Rhodus N.L., Ho V., Miller C.S., Myers S., Ondrey F. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 2005, 29:42-45.
6. Arellano-Garcia M.E., Hu S., Wang J., Henson B., Zhou H., Chia D., et al. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis 2008, 14:705-712.
7. Katakura A., Kamiyama I., Takano N., Shibahara T., Muramatsu T., Ishihara K., et al. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll 2007, 48:199-203.
8. Wong H.L., Pfeiffer R.M., Fears T.R., Vermeulen R., Ji S., Rabkin C.S. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008, 17:3450-3456.
9. Jablonska E., Piotrowski L., Grabowska Z. Serum levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in patients with oral cavity cancer. Pathol Oncol Res 1997, 3:126-129.
10. Azuma M., Tamatani T., Kasai Y., Sato M. Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori-mutant deoxyribonucleic acid. Lab Invest 1993, 69:24-42.
11. Brinkmann O., Wong D.T. Salivary transcriptome biomarkers in oral squamous cell cancer detection. Adv Clin Chem 2011, 55:21-34.
12. St John M.A., Li Y., Zhou X., Denny P., Ho C.M., Montemagno C., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004, 130:929-935.
13. Marcus B., Arenberg D., Lee J., Kleer C., Chepeha D.B., Schmalbach C.E., et al. Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 2004, 101:2779-2787.
14. Ray C.A., Bowsher R.R., Smith W.C., Devanarayan V., Willey M.B., Brandt J.T., et al. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal 2005, 36:1037-1044.
15. de Jager W., Rijkers G.T. Solid-phase and bead-based cytokine immunoassay: a comparison. Methods 2006, 38:294-303.
16. Miller C.S., King C.P., Langub M.C., Kryscio R.J., Thomas M.V. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006, 137:322-329.
17. Rawlinson A., Dalati M.H., Rahman S., Walsh T.F., Fairclough A.L. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000, 27:738-743.
18. Ishihara Y., Nishihara T., Kuroyanagi T., Shirozu N., Yamagishi E., Ohguchi M., et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 1997, 32:524-529.
19. König J.E., Tolnay E., Wiethege T., Müller K.M. Expression of vascular endothelial growth factor in diffuse malignant pleural mesothelioma. Virchows Arch 1999, 435:8-12.
20. Solà-Villà D., Camacho M., Solà R., Soler M., Diaz J.M., Vila L. IL-1 beta induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells. Kidney Int 2006, 70:1935-1941.
21. Tanaka T., Kanai H., Sekiguchi K., Aihara Y., Yokoyama T., Arai M., et al. Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 2000, 32:1955-1967.
22. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem 1996, 271:24313-24316.
23. Kobayashi M., Squires G.R., Mousa A., Tanzer M., Zukor D.J., Antoniou J., et al. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52:128-135.
24. SahebJamee M., Eslami M., Atarbashi Moghadam F., Sarafnejad A. Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2008, 13:E292-E295.